Perspective Therapeutics, Inc. — Director's Dealing 2016

Mar 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2016-03-08

Reporting Person: McCormick Michael W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-08	Common stock	P	22000	$0.867	Acquired	22000	Direct